Usability and User Experience of a Virtual Reality Rehabilitation Game Platform in Individuals Wi… (NCT07565272) | Clinical Trial Compass
By InvitationNot Applicable
Usability and User Experience of a Virtual Reality Rehabilitation Game Platform in Individuals With Duchenne Muscular Dystrophy
Turkey (Türkiye)6 participantsStarted 2026-04-28
Plain-language summary
This study aims to evaluate the usability, user experience, and tolerability of a virtual reality-based rehabilitation game platform specifically developed for individuals with Duchenne muscular dystrophy. Participants will complete a single-session gameplay experience using an immersive virtual reality headset with hand-tracking technology. Following the gameplay session, usability, enjoyment, and potential virtual reality-related discomfort will be assessed using standardized questionnaires and qualitative feedback. The study is exploratory and formative in nature and does not aim to evaluate clinical effectiveness.
Who can participate
Age range
7 Years
Sex
MALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Clinical diagnosis of Duchenne muscular dystrophy (DMD)
* Aged 7 years and older
* Brooke Upper Extremity Functional Classification level ≤ 4
* Ability to understand and follow simple instructions
* Ability to interact with the virtual reality system using upper extremities
* Willingness to participate and provide informed consent (parental/guardian consent where applicable)
Exclusion Criteria:
* Presence of neurological disorders other than DMD
* Severe visual impairment that prevents interaction with the virtual reality system
* Severe upper extremity contractures or deformities limiting participation
* Cognitive, behavioral, or communication impairments interfering with study procedures
* History of severe motion sickness or intolerance to virtual reality environments
* Any medical condition that may pose a risk during participation, as determined by the investigator
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Usability (System Usability Scale)
Timeframe: Immediately after the single-session gameplay